YZYijun Zhang

Yijun Zhang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yijun Zhang has a total of 44 co-authors. Here are the top co-authors by number of shared publications:

  • Anxin Wang

    Department of Epidemiology, Beijing Neurosurgical Institute, Beijing Tiantan Hospital, Capital Medical University, Beijing, China

    4 shared publications
  • Xia Meng

    China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, China

    3 shared publications
  • Xiaoli Zhang

    Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China

    2 shared publications
  • Xue Xia

    Department of Neurology, Beijing Tiantan Hospital Capital Medical University Beijing China

    2 shared publications
  • Baixue Jia

    Interventional Neuroradiology, Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, China

    1 shared publication
  • Dapeng Mo

    Interventional Neuroradiology, Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, China

    1 shared publication

Latest Publications

  • Open Access

    Burden of ischemic stroke in China from 1990 to 2050: A systematic review and analysis of Global Burden of Disease Study 2021

    by Yijun Zhang, Jinqiao Zhu, Xue Xia, Meng Gao, Yunyi Hao, Anxin Wang

    Background: Comprehensive understanding of the ischemic stroke (IS) burden in China is critical for policy and medical resource allocation. We aimed to identify the most up‐to‐date IS burden by age‐ and sex‐specific temporal trends in China and forecast to 2050. Methods: Based on the Global Burden of Disease, Injuries, and Risk Factors Study (GBD) 2021, we investigated the IS burden in China from 1990 to 2021. IS incidence and mortality data were extracted by age and sex. Temporal trends were assessed using joinpoint regression to calculate average annual percentage changes (AAPCs). The Auto‐regressive Integrated Moving Average (ARIMA) models, incorporating Socio‐demographic Index and proportion of population aged >65 years as external predictors, were used to forecast the IS burden in China from 2022 to 2050. Decomposition analysis was performed to quantify the contributions of population growth, aging, and epidemiological changes to the observed and projected burden shifts. Results: From 1990 to 2021, the age‐standardized incidence rate (ASIR) of IS increased (AAPC: 0.97%, 95% confidence interval [CI] 0.93–1.00); whereas the age‐standardized mortality rate (ASMR) decreased (AAPC: −0.49%, 95% CI −0.75 to −0.23). The ASIR increased faster (AAPC: 1.13% vs. 0.72%) and ASMR decreased slower in males than in females (AAPC: −0.14% vs. −0.89%) between 1990 and 2021. From 2021 to 2050, the ASIR will increase slower (AAPC: 0.77%; 95% CI 0.75–0.79) and the ASMR will decrease faster (AAPC: −1.53%; 95% CI −1.56 to −1.51). The ASIR will increase more pronounced in females (AAPC: 1.04%, 95% CI 1.02–1.07) than in males (AAPC: 0.56%, 95% CI 0.56–0.57) between 2021 and 2050. By 2050, those over 85 years old will have the highest incidence and mortality, the number of IS incident cases and deaths will reach 3.68 million (95% uncertainty interval [UI] 3.05–4.40) and 1.50 million (95% UI 1.27–1.76). The predominant factor leading to the growth of IS incident cases (54.04%) and deaths (73.2%) between 2021 and 2050 will be shifted to aging. Conclusions: The IS burden is expected to continue increasing through 2050 albeit at a slower rate. Notably, the ASIR of IS will increase faster in females than in males from 2021 to 2050. Technological innovation, effective policies, and more health spending are needed to curb this increase.


  • Relationship Between Thrombolysis-to-Puncture Time and Outcomes of Endovascular Thrombectomy in Acute Ischemic Stroke

    by Xu Tong, Baixue Jia, Gaoting Ma, Xuelei Zhang, Jens Fiehler, Fabian Flottmann, Matthias Bechstein, Gabriel Broocks, Uta Hanning, Helge C. Kniep, et al.

    Intravenous thrombolysis (IVT) followed by endovascular thrombectomy (EVT) improves functional outcomes in patients with acute ischemic stroke (AIS) caused by large vessel occlusion (LVO). There are limited data on the effect of thrombolysis-to-puncture time (TTP) on outcomes in patients with AIS undergoing IVT plus EVT. We selected 1,104 patients receiving IVT + EVT for anterior circulation LVO stroke from 2 prospective nationwide registries (259 cases from ANGEL-ACT in China: November 2017 to March 2019, 845 cases from German Stroke Registry-Endovascular Treatment in Germany: June 2015 to December 2019). Based on the TTP, eligible patients were divided into 4 groups (≤30 min, 31-50 min, 51-70 min, and >70 min). The radiologic and clinical outcomes (e.g., successful recanalization [modified Thrombolysis in Cerebral Infarction score of 2b-3] at final angiogram, modified Rankin Scale [mRS] score of 0-2 at 90 days, any intracranial hemorrhage [ICH], and symptomatic ICH within 24 hours) among the 4 groups were compared by χ2 tests for trend and using multivariable logistic regression models. In the 4 groups from ≤30 min to >70 min, 226, 282, 230, and 366 patients were included, respectively. An increased TTP was associated with a lower chance of successful recanalization (p = 0.016) and mRS score 0-2 (p = 0.002). Compared with the group of ≤30 min, the group of >70 min was less likely to achieve successful recanalization (adjusted odds ratio [OR] = 0.47, 95% CI 0.25-0.89) and the groups of 50-70 min and >70 min had a reduced probability of mRS score 0-2 (adjusted OR = 0.50, 95% CI 0.33-0.78; adjusted OR = 0.56, 95% CI 0.37-0.85). No significant differences were found for any ICH or symptomatic ICH among the 4 groups after adjustment with potential confounders. Delay from thrombolysis to puncture should be minimized when considering bridging IVT before EVT for patients with AIS due to anterior circulation LVO. Further studies are warranted to verify and expand on these findings. ClinicalTrials.gov, NCT03370939 and NCT03356392.


  • Open Access

    Associations between multiple acute infarctions and intracranial arterial stenosis with functional outcomes in anterior circulation acute ischaemic stroke reperfusion therapy: results from the China National Stroke Registry III

    by Shifeng Xiang, Yijun Zhang, Xiaoli Zhang, Ya Su, Xu Zhu, Yiping Wu, Anxin Wang, Xia Meng

    Objective This study aims to observe the correlation between infarction pattern and intracranial arterial stenosis (ICAS) on magnetic resonance and functional outcome in acute ischaemic stroke (AIS) patients after reperfusion therapy. Design This is a post hoc analysis of the Third China National Stroke Registry (CNSR-III) study. Setting The data was derived from the CNSR-III study, which was a nationwide clinical registry of ischaemic stroke or transient ischaemic attack based in China. Participants Patients with anterior circulation AIS who underwent reperfusion therapy were included for analysis. The patients were divided into single acute infarction and multiple acute infarctions (MAIs) based on the diffusion-weighted imaging findings. Additionally, patients were categorised according to the degree of ICAS assessed by magnetic resonance angiography as either ≥50% or Primary outcome measures The primary outcome of this study was poor functional outcome at 12 months, defined as a modified Rankin Scale of 3–6. Results In the included 796 patients, there were 152, 130 and 126 cases of unfavourable functional outcomes at 3 months, 6 months and 12 months, respectively. After adjusting for all potential confounding factors, MAIs were significantly associated with an increased risk of poor functional outcomes at 12 months (OR 1.96; 95% CI 1.27 to 3.02; p=0.0024). Similarly, ≥50% ICAS was also correlated with an increased risk of poor functional outcomes (OR 1.74; 95% CI 1.14 to 2.67; p=0.0110). Conclusions Both MAIs and ≥50% ICAS were associated with poor functional outcomes in patients with anterior circulation AIS who received reperfusion therapy.


  • Derivation and Validation of a Scoring System for Predicting Poor Outcome After Posterior Circulation Ischemic Stroke in China

    by Jialei Yang, Xiaoyu Lin, Anxin Wang, Xia Meng, Xingquan Zhao, Jing Jing, Yijun Zhang, Hao Li, Yongjun Wang

    Guidelines for posterior circulation ischemic stroke (PCIS) treatment are lacking and outcome prediction is crucial for patients and clinicians. We aimed to develop and validate a prognostic score to predict the poor outcome for patients with PCIS. The score was developed from a prospective derivation cohort named the Third China National Stroke Registry (August 2015-March 2018) and validated in a spatiotemporal independent validation cohort (December 2017-March 2023) in China. Patients with PCIS with acute infarctions defined as hyperintense lesions on diffusion-weighted imaging were included in this study. The poor outcome was measured as modified Rankin scale (mRS) score 3-6 at 3 months after PCIS. Multivariable logistic regression analysis was used to identify predictors for poor outcome. The prognostic score, namely PCIS Outcome Score (PCISOS), was developed by assigning points to variables based on their relative β-coefficients in the logistic model. The PCISOS was derived from 3,294 patients (median age 62 [interquartile range (IQR) 55-70] years; 2,250 [68.3%] men) and validated in 501 patients (median age 61 [IQR 53-68] years; 404 [80.6%] men). Among them, 384 (11.7%) and 64 (12.8%) had poor outcome 3 months after stroke in respective cohorts. Age, mRS before admission, NIH Stroke Scale on admission, ischemic stroke history, infarction distribution, basilar artery, and posterior cerebral artery stenosis or occlusion were identified as independent predictors for poor outcome and included in PCISOS. This easy-to-use integer scoring system identified a marked risk gradient between 4 risk groups. PCISOS performed better than previous scores, with an excellent discrimination (C statistic) of 0.80 (95% CI 0.77-0.83) in the derivation cohort and 0.81 (95% CI 0.77-0.84) in the validation cohort. Calibration test showed high agreement between the predicted and observed outcomes in both cohorts. PCISOS can be applied for patients with PCIS with acute infarctions to predict functional outcome at 3 months post-PCIS. This simple tool helps clinicians to identify patients with PCIS with higher risk of poor outcome and provides reliable outcome expectations for patients. This information might be used for personalized rehabilitation plan and patient selection for future clinical trials to reduce disability and mortality.


  • Open Access

    Monocyte to high‐density lipoprotein ratio predicts clinical outcomes after acute ischemic stroke or transient ischemic attack

    by Qin Xu, Qiong Wu, Lu Chen, Hao Li, Xue Tian, Xue Xia, Yijun Zhang, Xiaoli Zhang, Yongzhong Lin, Yiping Wu, et al.

    Aims: The monocyte to high‐density lipoprotein cholesterol ratio (MHR) has emerged as a novel inflammatory biomarker of atherosclerotic cardiovascular disease. However, it has not yet been identified whether MHR can predict the long‐term prognosis of ischemic stroke. We aimed to investigate the associations of MHR levels with clinical outcomes in patients with ischemic stroke or transient ischemic attack (TIA) at 3 months and 1 year.Methods: We derived data from the Third China National Stroke Registry (CNSR‐III). Enrolled patients were divided into four groups by quartiles of MHR. Multivariable Cox regression for all‐cause death and stroke recurrence and logistic regression for the poor functional outcome (modified Rankin Scale score 3–6) were used.Results: Among 13,865 enrolled patients, the median MHR was 0.39 (interquartile range, 0.27–0.53). After adjustment for conventional confounding factors, the MHR level in quartile 4 was associated with an increased risk of all‐cause death (hazard ratio [HR], 1.45; 95% confidence interval [CI], 1.10–1.90), and poor functional outcome (odd ratio [OR], 1.47; 95% CI, 1.22–1.76), but not with stroke recurrence (HR, 1.02; 95% CI, 0.85–1.21) at 1 year follow‐up, compared with MHR level in quartile 1. Similar results were observed for outcomes at 3 months. The addition of MHR to a basic model including conventional factors improved predictive ability for all‐cause death and poor functional outcome validated by the C‐statistic and net reclassification index (all p < 0.05).Conclusions: Elevated MHR can independently predict all‐cause death and poor functional outcome in patients with ischemic stroke or TIA.